Taiwan FDA registration 1a4484faaab8da5c25fd371015d7139a
Cemosir low molecular weight heparin tube solution
TW: 希摩西爾低分子量肝素品管液
Taiwan·Risk Class 2·INSTRUMENTATION LABORATORY CO.·Registered Aug 07, 2013 – Aug 07, 2028ActiveRegistration details
- Analysis ID
- 1a4484faaab8da5c25fd371015d7139a
- Customs Code
- DHA05602525701
Company information
- Manufacturer
- INSTRUMENTATION LABORATORY CO.
- Manufacturer Country
- United States
- Authorized Representative
- Werfen Taiwan Limited
Product details
- Intended Use
- This product is used with IL blood coagulation instrument system (ACL TOP series, ACL ELITE/ELITE PRO/8/9/10000, and ACL Futura/ACL Advance) as a low molecular weight heparin (LMWH) quality control of liquid heparin reagent.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.5425 Versatile system for in vitro agglutination studies
- Import Information
- import
Dates and status
- Registration Date
- Aug 07, 2013
- Expiry Date
- Aug 07, 2028
About this record
Access comprehensive regulatory information for Cemosir low molecular weight heparin tube solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1a4484faaab8da5c25fd371015d7139a and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices